01—Abstract
Summary
Summary of the 8-K filed February 13, 2019. Cited figures are marked; the original filing is the authoritative source.
This 8-K filing from Procter & Gamble Co. (PG) announces the retirement of Dr. Ernesto Zedillo from the Board of Directors, effective February 13, 2019.
Dr. Zedillo's departure is in line with the company's established corporate governance guidelines regarding term limits, concluding his 18-year tenure on the board. This event is being reported under Item 5.02(b) of the 8-K, which covers the departure of directors and certain officers.
02—Key points
Key Highlights
- Dr. Ernesto Zedillo retired from the Board of Directors.
- The retirement is effective February 13, 2019.
- Dr. Zedillo served on the Board for 18 years.
- The retirement adheres to the Company's Corporate Governance Guidelines on term limits.
- This is a routine board refreshment in accordance with company policy.
03—Questions
Frequently Asked Questions
Who is Dr. Ernesto Zedillo?
Dr. Ernesto Zedillo is a former President of Mexico who has served on the Procter & Gamble Board of Directors for 18 years.
Why is Dr. Zedillo retiring?
Dr. Zedillo is retiring in accordance with the company's Corporate Governance Guidelines, which stipulate term limits for board members.
Does this retirement indicate any issues with the company's governance or performance?
No, the filing explicitly states that the retirement is in accordance with established term limits, suggesting it is a planned and routine board succession rather than an indication of any issues.
Will a new director be appointed to replace Dr. Zedillo?
This specific 8-K filing only announces Dr. Zedillo's retirement. While the company typically aims to maintain optimal board composition, the filing does not detail immediate plans for a replacement. Investors would look for future filings for announcements regarding board appointments.
04—Continue